TY - JOUR U1 - Wissenschaftlicher Artikel A1 - Linke, Christina A1 - Ehlert, Karoline A1 - Ahlmann, Martina A1 - Fröhlich, Birgit A1 - Mohring, Daniela A1 - Burkhardt, Birgit A1 - Rössig, Claudia A1 - Groll, Andreas H. T1 - Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation JF - Mycoses N2 - Summary Background Epidemiology and management practices of invasive fungal diseases (IFD) after allogeneic haematopoietic stem cell transplantation (HSCT) are a subject of constant change. We investigated the contemporary incidence, diagnostics, antifungal management and outcome at a major paediatric transplant centre in Germany. Methods The single‐centre retrospective observational study included all paediatric allogeneic HSCT patients (pts) transplanted between 2005 and 2015. Patient‐related data were assessed up to 365 days post‐transplant. The primary endpoint was the incidence of possible, probable and proven IFDs. Secondary endpoints included diagnostics and antifungal treatment; analysis of risk factors; and overall survival with the last follow‐up in January 2017. Results A total of 221 first (196), second (21) or third (4) procedures were performed in 200 pts (median age: 9 years, range, 0.5‐22) for leukaemia/lymphoma (149) and non‐malignant disorders (72). Prophylaxis was administered in 208 HSCT procedures (94%; fluconazole, 116, mould‐active agents, 92). At least one computed tomography scan of the chest was performed in 146, and at least one galactomannan antigen assay in 60 procedures. There were 15 cases of proven (candidemia, 4; aspergillosis, 4) or probable (aspergillosis, 7) IFDs, accounting for an incidence rate of 6.8%. Overall mortality at last follow‐up was 30%; the occurrence of proven/probable IFDs was associated with a reduced survival probability (P < .001). Conclusion Morbidity and mortality from IFDs at our institution were consistent with data reported from other centres. Utilisation of healthcare resources for prevention, diagnosis and management of IFDs was considerable. KW - - KW - children KW - diagnostics KW - management KW - mycoses KW - transplantation Y1 - 2020 UN - https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-40596 SN - 1439-0507 SS - 1439-0507 U6 - https://doi.org/10.1111/myc.13029 DO - https://doi.org/10.1111/myc.13029 VL - 63 IS - 2 SP - 172 EP - 180 PB - Wiley CY - Hoboken, New Jersey ER -